ICD-9 Code 272.7
Lipidoses
Not Valid for Submission
272.7 is a legacy non-billable code used to specify a medical diagnosis of lipidoses. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
ICD-9: | 272.7 |
Short Description: | Lipidoses |
Long Description: | Lipidoses |
Convert 272.7 to ICD-10
The following crosswalk between ICD-9 to ICD-10 is based based on the General Equivalence Mappings (GEMS) information:
Code Classification
-
Endocrine, nutritional and metabolic diseases, and immunity disorders (240–279)
-
Other metabolic disorders and immunity disorders (270-279)
- 272 Disorders of lipoid metabolism
-
Other metabolic disorders and immunity disorders (270-279)
Information for Medical Professionals
Index to Diseases and Injuries
References found for the code 272.7 in the Index of Diseases and Injuries:
- Anderson s disease 272.7
- Anemia 285.9
- splenic 285.8
- familial Gaucher s 272.7
- splenic 285.8
- Angiokeratoma M9141 0 SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Neoplasm skin benign- corporis diffusum 272.7
- Angiokeratosis
- diffuse 272.7
- Angiomatosis 757.32
- corporis diffusum universale 272.7
- Cerebrosidosis 272.7
- Ceroid storage disease 272.7
- Degeneration degenerative
- brain cortical progressive 331.9
- in
- Babry s disease 272.7 330.2
- Gaucher s disease 272.7 330.2
- lipidosis
- generalized 272.7 330.2
- Niemann Pick disease 272.7 330.2
- sphingolipidosis 272.7 330.2
- in
- brain cortical progressive 331.9
- Diabetes diabetic brittle congenital familial mellitus severe slight without complication 250.0
- lipoidosis 250.8 272.7
- due to secondary diabetes 249.8 272.7
- secondary chemical induced due to chronic condition due to infection drug induced 249.0
- lipoidosis 249.8 272.7
- lipoidosis 250.8 272.7
- Disease diseased SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Syndrome- Anderson s angiokeratoma corporis diffusum 272.7
- ceroid storage 272.7
- Fabry s angiokeratoma corporis diffusum 272.7
- Gaucher s adult cerebroside lipidosis infantile 272.7
- I cell 272.7
- lipidosis 272.7
- lipoid storage NEC NEC "Not elsewhere classifiable"
This abbreviation in the index represents “other specified” when a specific code is not available for a condition the index directs the coder to the “other specified” code in the tabular. 272.7
- mucolipidosis I II III 272.7
- Niemann Pick lipid histiocytosis 272.7
- Pick s
- lipid histiocytosis 272.7
- pseudo Hurler s mucolipidosis III 272.7
- storage
- lipid 272.7
- Sweeley Klionsky 272.7
- triglyceride storage type I II III 272.7
- Wolman s primary familial xanthomatosis 272.7
- Disorder SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Disease- lipid
- storage 272.7
- lipid
- Disturbance SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Disease- metabolism acquired congenital SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Disorder metabolism 277.9- phosphatides 272.7
- metabolism acquired congenital SEE ALSO See Also
- Dystrophy dystrophia 783.9
- retina retinal hereditary 362.70
- in
- systemic lipidosis 272.7 362.71
- in
- retina retinal hereditary 362.70
- Fabry s disease angiokeratoma corporis diffusum 272.7
- Gaucher s
- disease adult cerebroside lipidosis infantile 272.7
- hepatomegaly 272.7
- splenomegaly cerebroside lipidosis 272.7
- Hepatomegaly SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Hypertrophy liver 789.1- Gaucher s 272.7
- Histiocytosis acute chronic subacute 277.89
- lipid lipoid essential 272.7
- Hyperlipidosis 272.7
- hereditary 272.7
- Lipidosis 272.7
- cephalin 272.7
- cerebral infantile juvenile late 330.1
- cerebroretinal 330.1 362.71
- cerebroside 272.7
- cerebrospinal 272.7
- chemically induced 272.7
- cholesterol 272.7
- diabetic 250.8 272.7
- due to secondary diabetes 249.8 272.7
- dystopic hereditary 272.7
- glycolipid 272.7
- hepatosplenomegalic 272.3
- hereditary dystopic 272.7
- sulfatide 330.0
- Lipoid SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. condition- histiocytosis 272.7
- essential 272.7
- histiocytosis 272.7
- Lipoidosis SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Lipidosis 272.7 - Mucolipidosis I II III 272.7
- Niemann Pick disease lipid histiocytosis splenomegaly 272.7
- Pick s
- disease
- lipid histiocytosis 272.7
- disease
- Pick Niemann disease lipid histiocytosis 272.7
- Pseudo Hurler s disease mucolipidosis III 272.7
- Purpura 287.2
- hemorrhagic SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Purpura thrombocytopenic 287.39- nodular 272.7
- hemorrhagic SEE ALSO See Also
- Ruiter Pompen Wyers syndrome angiokeratoma corporis diffusum 272.7
- Sea blue histiocyte syndrome 272.7
- Sphingolipidosis 272.7
- Sphingolipodystrophy 272.7
- Sphingomyelinosis 272.7
- Splenomegaly 789.2
- Gaucher s cerebroside lipidosis 272.7
- Niemann Pick lipid histiocytosis 272.7
- Sweeley Klionsky disease angiokeratoma corporis diffusum 272.7
- Syndrome SEE ALSO See Also
A “see also” instruction following a main term in the index instructs that there is another main term that may also be referenced that may provide additional index entries that may be useful. It is not necessary to follow the “see also” note when the original main term provides the necessary code. Disease- cardiovasorenal 272.7
- Fabry Anderson angiokeratoma corporis diffusum 272.7
- Niemann Pick lipid histiocytosis 272.7
- Ruiter Pompen Wyers angiokeratoma corporis diffusum 272.7
- sea blue histiocyte 272.7
- Thesaurismosis
- kerasin 272.7
- lipoid 272.7
- phosphatide 272.7
- Trihexosidosis 272.7
- Wolman s disease primary familial xanthomatosis 272.7
- Xanthoma s xanthomatosis 272.2
- bone 272.7
- cutaneotendinous 272.7
- disseminatum 272.7
- familial 272.7
- hereditary 272.7
- infantile 272.7
- joint 272.7
- juvenile 272.7
- multiple 272.7
- multiplex 272.7
- primary familial 272.7
- tendon sheath 272.7
Information for Patients
Gaucher Disease
Gaucher disease is a rare, inherited disorder. It is a type of lipid metabolism disorder. If you have it, you do not have enough of an enzyme called glucocerebrosidase. This causes too much of a fatty substance to build up in your spleen, liver, lungs, bones and, sometimes, your brain. This prevents these organs from working properly.
There are three types:
- Type 1, the most common form, causes liver and spleen enlargement, bone pain and fractures (broken bones), and, sometimes, lung and kidney problems. It does not affect the brain. It can occur at any age.
- Type 2, which causes severe brain damage, appears in infants. Most children who have it die by age 2.
- In type 3, there may be liver and spleen enlargement. The brain is gradually affected. It usually starts in childhood or adolescence.
Gaucher disease has no cure. Treatment options for types 1 and 3 include medicine and enzyme replacement therapy, which is usually very effective. There is no good treatment for the brain damage of types 2 and 3.
NIH: National Institute of Neurological Disorders and Stroke
[Read More]
Genetic Brain Disorders
A genetic brain disorder is caused by a variation or a mutation in a gene. A variation is a different form of a gene. A mutation is a change in a gene. Genetic brain disorders affect the development and function of the brain.
Some genetic brain disorders are due to random gene mutations or mutations caused by environmental exposure, such as cigarette smoke. Other disorders are inherited, which means that a mutated gene or group of genes is passed down through a family. They can also be due to a combination of both genetic changes and other outside factors.
Some examples of genetic brain disorders include:
- Leukodystrophies
- Phenylketonuria
- Tay-Sachs disease
- Wilson disease
Many people with genetic brain disorders fail to produce enough of certain proteins that influence brain development and function. These brain disorders can cause serious problems that affect the nervous system. Some have treatments to control symptoms. Some are life-threatening.
[Read More]
ICD-9 Footnotes
General Equivalence Map Definitions
The ICD-9 and ICD-10 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- Approximate Flag - The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
- No Map Flag - The no map flag indicates that a code in the source system is not linked to any code in the target system.
- Combination Flag - The combination flag indicates that more than one code in the target system is required to satisfy the full equivalent meaning of a code in the source system.
Index of Diseases and Injuries Definitions
- And - The word "and" should be interpreted to mean either "and" or "or" when it appears in a title.
- Code also note - A "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
- Code first - Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists, there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
- Type 1 Excludes Notes - A type 1 Excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- Type 2 Excludes Notes - A type 2 Excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.
- Includes Notes - This note appears immediately under a three character code title to further define, or give examples of, the content of the category.
- Inclusion terms - List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- NEC "Not elsewhere classifiable" - This abbreviation in the Alphabetic Index represents "other specified". When a specific code is not available for a condition, the Alphabetic Index directs the coder to the "other specified” code in the Tabular List.
- NOS "Not otherwise specified" - This abbreviation is the equivalent of unspecified.
- See - The "see" instruction following a main term in the Alphabetic Index indicates that another term should be referenced. It is necessary to go to the main term referenced with the "see" note to locate the correct code.
- See Also - A "see also" instruction following a main term in the Alphabetic Index instructs that there is another main term that may also be referenced that may provide additional Alphabetic Index entries that may be useful. It is not necessary to follow the "see also" note when the original main term provides the necessary code.
- 7th Characters - Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.
- With - The word "with" should be interpreted to mean "associated with" or "due to" when it appears in a code title, the Alphabetic Index, or an instructional note in the Tabular List. The word "with" in the Alphabetic Index is sequenced immediately following the main term, not in alphabetical order.